Publicaciones en colaboración con investigadores/as de Instituto de Química Orgánica General (15)

2024

  1. Axonal Growth and Fasciculation of Spinal Neurons Promoted by Aldynoglia in Alkaline Fibrin Hydrogel: Influence of Tol-51 Sulfoglycolipid

    International Journal of Molecular Sciences, Vol. 25, Núm. 17

  2. Transplantation of Predegenerated Peripheral Nerves after Complete Spinal Cord Transection in Rats: Effect of Neural Precursor Cells and Pharmacological Treatment with the Sulfoglycolipid Tol-51

    Cells, Vol. 13, Núm. 16

2023

  1. Fast and Sustained Axonal Growth by BDNF Released from Chitosan Microspheres

    Marine Drugs, Vol. 21, Núm. 2

2020

  1. Unraveling the Structural Landscape of Chitosan-Based Heparan Sulfate Mimics Binding to Growth Factors: Deciphering Structural Determinants for Optimal Activity

    ACS Applied Materials and Interfaces, Vol. 12, Núm. 23, pp. 25534-25545

2018

  1. A holistic approach to unravelling chondroitin sulfation: Correlations between surface charge, structure and binding to growth factors

    Carbohydrate Polymers, Vol. 202, pp. 211-218

  2. Biochemical profiling of rat embryonic stem cells grown on electrospun polyester fibers using synchrotron infrared microspectroscopy

    Analytical and Bioanalytical Chemistry, Vol. 410, Núm. 16, pp. 3649-3660

  3. Synthesis, physicochemical characterization and biological evaluation of chitosan sulfate as heparan sulfate mimics

    Carbohydrate Polymers, Vol. 191, pp. 225-233

2015

  1. Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment

    Restorative Neurology and Neuroscience, Vol. 33, Núm. 6, pp. 895-910

  2. Mass spectrometry in pharmacokinetic studies of a synthetic compound for spinal cord injury treatment

    BioMed Research International, Vol. 2015

2014

  1. Sustratos electrohilados de poli(hidroxibutirato-co-hidroxihexanoato) con glicósidos para reparación de la lesión medular

    Trauma (Spain), Vol. 25, Núm. 2, pp. 63-73

2013

  1. Synthetic glycolipids for glioma growth inhibition developed from neurostatin and NF115 compound

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 2, pp. 435-439

2011

  1. Lipid and ganglioside alterations in tumor cells treated with antimitotic oleyl glycoside

    Molecular BioSystems, Vol. 7, Núm. 1, pp. 129-138

2009

  1. Detection of metabolite changes in C6 glioma cells cultured with antimitotic oleyl glycoside by1H MAS NMR

    Journal of Medicinal Chemistry, Vol. 52, Núm. 5, pp. 1263-1267

2007

  1. Design and synthesis of glycoside inhibitors of glioma and melanoma growth

    Journal of Medicinal Chemistry, Vol. 50, Núm. 2, pp. 364-373

2004

  1. Natural, synthetic and semisynthetic glycolipid inhibitors of glioma growth

    Expert Opinion on Therapeutic Patents, Vol. 14, Núm. 4, pp. 487-497